Stock Events

Stock Events

Search...

ALPS Medical Breakthroughs

$37.33

7

+$0.06+0.16% Monday 20:00

Statistics

Day High

37.78

Day Low

37.06

52W High

39.37

52W Low

23.21

Volume

5,190

Avg. Volume

5,882

Mkt Cap

-

P/E Ratio

-

Dividend Yield

0.19%

Dividend

0.07

Upcoming

Dividend Payment

Dividend Payment

Dividends

0.19%Dividend Yield

10Y Growth

N/A

5Y Growth

35%

3Y Growth

N/A

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SBIO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

iShares Biotechnology

iShares Nasdaq Biotechnology ETF, competes as it also invests in biotechnology and pharmaceutical companies, offering a similar focus on the sector.

SPDR S&P Biotech ETF, directly competes by investing in biotechnology companies, with a broad exposure to the industry.

VanEck Vectors Biotech ETF, competes by focusing on biotech firms, similar to SBIO's investment strategy.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund, offers competition by targeting biotech firms, providing an alternative in the sector.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF, competes by investing in biotech and genome companies, offering a similar thematic investment.

Virtus LifeSci Biotech Products

Virtus LifeSci Biotech Products ETF, competes by focusing on biotech product companies, closely aligning with SBIO's investment focus.

ARK Genomic Revolution

ARK Genomic Revolution ETF, competes by focusing on genomics and biotech, offering innovative healthcare investment opportunities.

Global X Genomics & Biotechnology

Global X Genomics & Biotechnology ETF, competes by investing in companies involved in genomics and biotech, similar to SBIO's focus.

iShares Genomics Immunology and Healthcare

iShares Genomics Immunology and Healthcare ETF, competes by focusing on genomics, immunology, and healthcare, offering a similar investment theme.

About

Miscellaneous

Investment Trusts/Mutual Funds

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

Show more...

CEO

Country

US

ISIN

US00162Q5936

Listings